These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9331711)
41. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348 [TBL] [Abstract][Full Text] [Related]
42. [Genetic characteristic of toxigenicity of group A streptococci cultures isolated from patients with tonsillitis]. Kravchenko IE; Dmitrieva NF; Eshchina AS; Kirillov MIu; Timofeev IuM; Briko NI Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):76-8. PubMed ID: 19338240 [TBL] [Abstract][Full Text] [Related]
43. Biological significance of the genetic linkage between streptolysin S expression and riboflavin biosynthesis in Streptococcus pyogenes. Gargir A; Liu S; Sela S; Cohen G; Jadoun J; Cheung A; Ofek I Adv Exp Med Biol; 1997; 418():987-9. PubMed ID: 9331816 [No Abstract] [Full Text] [Related]
44. Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells. Müller-Alouf H; Capron M; Alouf JE; Geoffroy C; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM Adv Exp Med Biol; 1997; 418():929-31. PubMed ID: 9331802 [No Abstract] [Full Text] [Related]
45. Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli. Fagin U; Hahn U; Grötzinger J; Fleischer B; Gerlach D; Buck F; Wollmer A; Kirchner H; Rink L Infect Immun; 1997 Nov; 65(11):4725-33. PubMed ID: 9353057 [TBL] [Abstract][Full Text] [Related]
46. Streptolysin O modulates cytokine synthesis in human peripheral blood mononuclear cells. Stevens DL; Bryant AE Adv Exp Med Biol; 1997; 418():925-7. PubMed ID: 9331801 [No Abstract] [Full Text] [Related]
47. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. Nakashima K; Ichiyama S; Iinuma Y; Hasegawa Y; Ohta M; Ooe K; Shimizu Y; Igarashi H; Murai T; Shimokata K Clin Infect Dis; 1997 Aug; 25(2):260-6. PubMed ID: 9332521 [TBL] [Abstract][Full Text] [Related]
48. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. Eriksson BK; Andersson J; Holm SE; Norgren M J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857 [TBL] [Abstract][Full Text] [Related]
49. Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion. Johnson LP; Schlievert PM; Watson DW Infect Immun; 1980 Apr; 28(1):254-7. PubMed ID: 6991440 [TBL] [Abstract][Full Text] [Related]
50. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Rasmussen M; Björck L Mol Microbiol; 2002 Feb; 43(3):537-44. PubMed ID: 11929513 [TBL] [Abstract][Full Text] [Related]
51. Flesh-eating bacteria: not new, but still worrisome. Nowak R Science; 1994 Jun; 264(5166):1665. PubMed ID: 8209244 [No Abstract] [Full Text] [Related]
52. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222 [TBL] [Abstract][Full Text] [Related]
53. [The return of severe infections caused by Streptococcus pyogenes]. Verhoef-Verhage EA; van Houten A; Joore JC; Verbrugh HA Ned Tijdschr Geneeskd; 1993 Mar; 137(12):604-7. PubMed ID: 8459859 [TBL] [Abstract][Full Text] [Related]
54. Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes. Chiang-Ni C; Wu JJ J Formos Med Assoc; 2008 Sep; 107(9):677-85. PubMed ID: 18796357 [TBL] [Abstract][Full Text] [Related]
55. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Shelburne SA; Granville C; Tokuyama M; Sitkiewicz I; Patel P; Musser JM Infect Immun; 2005 Aug; 73(8):4723-31. PubMed ID: 16040985 [TBL] [Abstract][Full Text] [Related]
56. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. Holm SE; Köhler W; Kaplan EL; Schlievert PM; Alouf JE; Stevens DL; Kotb M Adv Exp Med Biol; 1997; 418():193-9. PubMed ID: 9331631 [No Abstract] [Full Text] [Related]
57. Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase). Gerlach D; Reichardt W; Fleischer B; Schmidt KH Zentralbl Bakteriol; 1994 Mar; 280(4):507-14. PubMed ID: 8061411 [TBL] [Abstract][Full Text] [Related]
58. Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes. Unnikrishnan M; Cohen J; Sriskandan S Infect Immun; 1999 Oct; 67(10):5495-9. PubMed ID: 10496938 [TBL] [Abstract][Full Text] [Related]
59. [Streptococcus pyogenes--pathogenetic factors and their involvement in the pathogenesis of acute streptococcal infections and their complications]. Ungureanu V Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):34-47. PubMed ID: 8173211 [No Abstract] [Full Text] [Related]
60. Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus pyogenes. Jansen WT; Bolm M; Balling R; Chhatwal GS; Schnabel R Infect Immun; 2002 Sep; 70(9):5202-7. PubMed ID: 12183571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]